902520

Vertex Pharmaceuticals Incorporated — FEI 1000513211

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 16, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report